David Vlahov, RN, PhD, FAAN

Headshot of David Vlahov
User Profile Photo

David Vlahov, RN, PhD, FAAN

User Profile Name
Dean, UCSF School of Nursing
Professor Emeritus, School of Nursing
User Profile Title
User Profile Email

Biography

Dr. Vlahov is Professor Emeritus at the University of California, San Francisco School of Nursing after serving five years as Dean. He served on the faculty as Professor of Epidemiology at the Johns Hopkins and Columbia Universities, and was Adjunct Professor in Medical Schools at Cornell, Mount Sinai and New York University and the College of Nursing at New York University. He has also served as co-Director of the National Program Office(NPO) for the Robert Wood Johnson Foundation Health and Society Scholars program and currently, the NPO for the Foundation's Evidence for Action program. He brings research expertise in urban health, epidemiology, infectious diseases, substance abuse and mental health. Dr. Vlahov conducted studies of urban populations in Baltimore for over 20 years including several longitudinal cohort studies for which he received the NIH MERIT Award. More recently, Dr. Vlahov led epidemiologic studies in Harlem and the Bronx, which have served as a platform for subsequent individual- and community-level intervention studies and community based participatory research (involving partnerships with residents, community based organizations, academic/ public health departments) to address social determinants of health. This work has contributed information on racial/ethnic disparities in health and approaches to address such disparities. Uniting these interests, Dr. Vlahov became Director of the Center for Urban Epidemiologic Studies at the New York Academy of Medicine He was a Visiting Professor at the Medical School in Belo Horizonte, Brazil to develop their programs in urban health, and has been an expert consultant to the WHO’s Urban Health Center in Kobe, Japan. He served on the New York City Board of Health during the Bloomberg administration. Dr. Vlahov is the editor-in-chief of the Journal of Urban Health, has edited three books on urban health and published over 650 scholarly papers. With colleagues he initiated the International Society for Urban Health (www.isuh.org), serving as its first President. He is a member of the National Academy of Medicine (formerly theInstitute of Medicine) and a Fellow of the American Academy of Nursing. He has served on the Board of Directors for the American Association of Colleges of Nursing and as a member on the National Advisory Council for Nursing Education and Practice at HRSA.
CTSI Profile Bio

Displaying 551 - 575 of 679

  1. Harrison K, Vlahov D, Jones K, Charron K, Clements ML. Medical eligibility, comprehension of the consent process, and retention of injection drug users recruited for an HIV vaccine trial. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Nov 01; 10(3):386-90.
  2. Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Arch Intern Med. 1995 Oct 23; 155(19):2111-7.
  3. Serpelloni G, Vlahov D, Mazzi M, Rezza G. Interest in HIV vaccines among Italian injection drug users. The Network Interregionale SERT. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Oct 01; 10(2):206-7.
  4. Gleghorn AA, Jones TS, Doherty MC, Celentano DD, Vlahov D. Acquisition and use of needles and syringes by injecting drug users in Baltimore, Maryland. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 01; 10(1):97-103.
  5. Vlahov D. Deregulation of the sale and possession of syringes for HIV prevention among injection drug users. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Sep 01; 10(1):71-2.
  6. Gershon RR, Vlahov D, Felknor SA, Vesley D, Johnson PC, Delclos GL, Murphy LR. Compliance with universal precautions among health care workers at three regional hospitals. Am J Infect Control. 1995 Aug; 23(4):225-36.
  7. Levine OS, Vlahov D, Koehler J, Cohn S, Spronk AM, Nelson KE. Seroepidemiology of hepatitis B virus in a population of injecting drug users. Association with drug injection patterns. Am J Epidemiol. 1995 Aug 01; 142(3):331-41.
  8. Thomas DL, Vlahov D, Solomon L, Cohn S, Taylor E, Garfein R, Nelson KE. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995 Jul; 74(4):212-20.
  9. Holmberg SD, Conley LJ, Luby SP, Cohn S, Wong LC, Vlahov D. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jul 01; 9(3):291-6.
  10. Nelson KE, Vlahov D, Solomon L, Cohn S, Muñoz A. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, Md. Arch Intern Med. 1995 Jun 26; 155(12):1305-11.
  11. Dorrucci M, Rezza G, Vlahov D, Pezzotti P, Sinicco A, Nicolosi A, Lazzarin A, Galai N, Gafà S, Pristerà R. Clinical characteristics and prognostic value of acute retroviral syndrome among injecting drug users. Italian Seroconversion Study. AIDS. 1995 Jun; 9(6):597-604.
  12. Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, Maryland, U.S.A. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 May 01; 9(1):89-96.
  13. Concha M, Selnes OA, McArthur JC, Nance-Sproson T, Updike ML, Royal W, Solomon L, Vlahov D. Normative data for a brief neuropsychologic test battery in a cohort of injecting drug users. Int J Addict. 1995 May; 30(7):823-41.
  14. Semba RD, Caiaffa WT, Graham NM, Cohn S, Vlahov D. Vitamin A deficiency and wasting as predictors of mortality in human immunodeficiency virus-infected injection drug users. J Infect Dis. 1995 May; 171(5):1196-202.
  15. Markham RB, Yu X, Farzadegan H, Ray SC, Vlahov D. Human immunodeficiency virus type 1 env and p17gag sequence variation in polymerase chain reaction-positive, seronegative injection drug users. J Infect Dis. 1995 Apr; 171(4):797-804.
  16. Künzi MS, Farzadegan H, Margolick JB, Vlahov D, Pitha PM. Identification of human immunodeficiency virus primary isolates resistant to interferon-alpha and correlation of prevalence to disease progression. J Infect Dis. 1995 Apr; 171(4):822-8.
  17. Gershon RR, Vlahov D, Farzadegan H, Alter MJ. Occupational risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infections among funeral service practitioners in Maryland. Infect Control Hosp Epidemiol. 1995 Apr; 16(4):194-7.
  18. Latkin C, Mandell W, Oziemkowska M, Celentano D, Vlahov D, Ensminger M, Knowlton A. Using social network analysis to study patterns of drug use among urban drug users at high risk for HIV/AIDS. Drug Alcohol Depend. 1995 Apr; 38(1):1-9.
  19. Sorkin JD, Bolton PA, Greenblatt J, Sithisarankul P, Vlahov D, Graham NM. Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology. 1995 Mar; 6(2):172-7.
  20. Galai N, Vlahov D, Margolick JB, Chen K, Graham NM, Muñoz A. Changes in markers of disease progression in HIV-1 seroconverters: a comparison between cohorts of injecting drug users and homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 01; 8(1):66-74.
  21. Roca J, Vlahov D, Borrell C, Jansa JM, Brugal T, Yazbeck H, Muñoz A. Geographic variation in HIV infection among injecting drug users with Barcelona. Int J Addict. 1995 Jan; 30(2):219-29.
  22. Gershon RR, Vlahov D, Kelen G, Conrad B, Murphy L. Review of accidents/injuries among emergency medical services workers in Baltimore, Maryland. Prehosp Disaster Med. 1995 Jan-Mar; 10(1):14-8.
  23. Caiaffa WT, Vlahov D, Graham NM, Astemborski J, Solomon L, Nelson KE, Muñoz A. Drug smoking, Pneumocystis carinii pneumonia, and immunosuppression increase risk of bacterial pneumonia in human immunodeficiency virus-seropositive injection drug users. Am J Respir Crit Care Med. 1994 Dec; 150(6 Pt 1):1493-8.
  24. Kline RL, Vlahov D, Quinn TC. Improved detection of HTLV-II antibody using a whole viral lysate-based EIA. J Acquir Immune Defic Syndr (1988). 1994 Dec; 7(12):1291-2.
  25. Khabbaz RF, Ksiazek TG, Caiaffa WT, Rollin PE, Taylor E, Vlahov D. Seoul hantavirus seropositivity among injecting drug users in Baltimore. J Infect Dis. 1994 Dec; 170(6):1636-7.